SPP1 and colorectal carcinoma: stClinic reveals distinct niches such as TAMs in aggressive tumors, B and plasma cells in favorable prognoses, and SPP1+ MTRNR2L12+ myeloid cells and CAFs in CRC adaptation and invasion.